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J Appl Physiol 117: 669–678, 2014. First published June 26, 2014;
doi:10.1152/japplphysiol.00088.2014.—Few studies have evaluated
the relationship between the duration of obesity, cardiac function, and
the proteins involved in myocardial calcium (Ca2) handling. We
hypothesized that long-term obesity promotes cardiac dysfunction due
to a reduction of expression and/or phosphorylation of myocardial
Ca2-handling proteins. Thirty-day-old male Wistar rats were distrib-
uted into two groups (n  10 each): control (C; standard diet) and
obese (Ob; high-fat diet) for 30 wk. Morphological and histological
analyses were assessed. Left ventricular cardiac function was assessed
in vivo by echocardiographic evaluation and in vitro by papillary
muscle. Cardiac protein expression of sarcoplasmic reticulum (SR)
Ca2-ATPase (SERCA2a), calsequestrin, L-type Ca2 channel, and
phospholamban (PLB), as well as PLB serine-16 phosphorylation
(pPLB Ser16) and PLB threonine-17 phosphorylation (pPLB Thr17)
were determined by Western blot. The adiposity index was higher
(82%) in Ob rats than in C rats. Obesity promoted cardiac hypertrophy
without alterations in interstitial collagen levels. Ob rats had increased
endocardial and midwall fractional shortening, posterior wall short-
ening velocity, and A-wave compared with C rats. Cardiac index,
early-to-late diastolic mitral inflow ratio, and isovolumetric relaxation
time were lower in Ob than in C. The Ob muscles developed similar
baseline data and myocardial responsiveness to increased extracellular
Ca2. Obesity caused a reduction in cardiac pPLB Ser16 and the pPLB
Ser16/PLB ratio in Ob rats. Long-term obesity promotes alterations in
diastolic function, most likely due to the reduction of pPLB Ser16, but
does not impair the myocardial Ca2 entry and recapture to SR.
high-fat diet; obesity; cardiac dysfunction; Ca2-handling proteins;
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OBESITY HAS BECOME THE MOST common metabolic and nutri-
tional disorder in industrial countries, and represents one of the
most prevalent risk factors for the development of common
chronic metabolic diseases (22, 37). The association between
obesity and the increased risk for the several chronic diseases
affecting morbidity and mortality in the population, including
cardiovascular disease, has been described in multiple epide-
miological studies (7).
Obesity is associated with a high chronic cardiac workload,
due to the need to supply more blood to peripheral tissues, and
frequently leads to left ventricular (LV) dysfunction (69).
Within this context, several authors have shown that cardiac
dysfunction is associated with the degree and duration of
obesity (1, 64). Studies suggest that early, subtle cardiomyo-
cyte hypertrophy and interstitial matrix expansion may predate
organ-level pathology. Long-term obese people exhibit a car-
diometabolic profile, including LV hypertrophy, diastolic dys-
function, and increased vascular stiffness, which are precursors
of future heart failure (1, 42, 54, 60). Although it is apparent
that a variety of alterations or damage in cardiac performance,
both in human and experimental models, occurs with eleva-
tions in adipose tissue content (1, 4, 32, 46, 56, 60), the
mechanisms responsible for these abnormalities are not com-
pletely understood after long-term exposure to obesity. There-
fore, this disease plays an important role in cardiovascular
morbidity through multiple mechanisms, including intracellu-
lar calcium (Ca2) handling (32, 50, 53, 56).
The literature reports that intracellular Ca2-cycling proteins
located in the sarcolemma and sarcoplasmic reticulum (SR),
such as the L-type Ca2 channel, SR Ca2-ATPase
(SERCA2a), phospholamban (PLB), and calsequestrin (CSQ),
regulate Ca2 homeostasis in cardiac muscle by modulating
myocardial contraction and relaxation (8, 50). Previous studies
have also shown that protein regulation of cardiac SR, a major
regulator of Ca2 handling during the cardiac excitation-
contraction-relaxation cycle, is mediated mainly by the activity
of SERCA2a (8, 21, 51, 68). SERCA2a activity is directly
modulated by the natural inhibitory phosphoprotein PLB,
which in its dephosphorylated state inhibits the apparent affin-
ity of SERCA2a for Ca2 (30, 66, 71). PLB can be phosphor-
ylated at three distinct sites in vitro: serine-16 (Ser16) by
cAMP- and cGMP-dependent protein kinases, threonine-17
(Thr17) by Ca2-calmodulin-dependent protein kinase II
(CaMKII), and Ser16 by protein kinase C (8, 14, 66). Upon
phosphorylation of PLB through -adrenergic stimulation and
enhanced cAMP-dependent protein kinase A (PKA) activity,
the inhibition of SERCA2a by PLB is relieved. PLB phosphor-
ylation acts as a molecular switch that activates SERCA2a,
which increases the calcium gradient across the SR during
diastole, and accelerates relaxation (8, 29).
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Alterations of intracellular Ca2 handling in cardiac dys-
function models may be caused by impairment of protein
expression, function, and phosphorylation, due to changes in
transcription, translation, and/or posttranslational processes.
Thus it is necessary to establish the mechanisms of affecting
Ca2-handling proteins after prolonged periods of obesity in
cardiac function.
Considering the lack of information regarding the mecha-
nisms underlying the participation of Ca2 handling in cardiac
function during prolonged periods of obesity, the objective of
this study was to test the hypothesis that an extended duration
of obesity leads to cardiac dysfunction and that this damage is
associated with a reduction in the expression and/or phosphor-
ylation of protein levels. These alterations could contribute to
reduced Ca2 entry and SR Ca2 reuptake; both are essential
for normal cardiac function.
MATERIALS AND METHODS
Animals and Experimental Design
Thirty-day-old male Wistar rats were obtained from the Central
Animal House of Botucatu Medical School (São Paulo, Brazil) and
randomly submitted to control (C, n  10) or obese (Ob, n  10)
treatment. The C group was fed a standard diet (RC Focus 1765;
Agroceres, Rio Claro, SP, Brazil), and the Ob group was alternately
submitted to four palatable high-fat diets (RC Focus 2413, 2414,
2415, and 2416; Agroceres, Rio Claro, Brazil) for 33 wk. The high-fat
diets were calorically rich (high-fat diet  3.65 kcal/g vs. low-fat
diet  2.95 kcal/g) due to their higher fat energy (consisting of
saturated and unsaturated fatty acids, which provided 20% and 80% of
the fat-derived calories, respectively). Standard and high-fat diet
components have been previously described (31).
All animals had free access to water and chow (50 g/day). After
starting the experimental protocol, body weight was recorded weekly.
Rats were individually caged and subjected to different dietary
regimens. Animals were kept under standard environmental con-
ditions of controlled light (12:12-h light-dark schedule; lights on at
6 AM), clean-air room temperature (23  3°C), and relative
humidity (60  5%).
All procedures involving animals were approved by the Ethics
Committee of Botucatu Medical School (UNESP, SP, Brazil) under
Study Number 573 and performed in accordance with the Guide for
the Care and Use of Laboratory Animals published by the US
National Institutes of Health (NIH Publication, 1996).
Characterization of Obesity
The adiposity index was measured to assess obesity. After animals
had been anesthetized with intramuscular injection of ketamine (50
mg/kg) and xylazine (0.5 mg/kg), decapitated, and thoracotomized,
the adipose tissue fat pads were dissected and weighed. The adiposity
index was calculated with the following formula: adiposity index 
[total body fat (BF)/final body wt]  100. BF was measured from the
sum of the individual fat pad weights as follows: BF  epididymal
fat  retroperitoneal fat  visceral fat.
Comorbidities Associated With Obesity
Systolic blood pressure. At the end of the experiment (at 33 wk),
the tail systolic blood pressure (SBP) was assessed in each animal
with a semiautomated tail cuff device, Narco BioSystems PE 300
(International Biomedical, Austin, TX). Two pressure measurements
were recorded.
Metabolic profile. At the end of the experimental period (at 33 wk),
animals were fasted for 12–15 h, anesthetized with an intramuscular
injection of ketamine (50 mg/kg) and xylazine (0.5 mg/kg), and
euthanized by decapitation. Blood samples were collected and the
serum was separated by centrifugation at 3,000 g for 15 min at 4°C
and stored at 80°C until further analysis. Serum was analyzed for
levels of glucose, triglycerides (TG), total cholesterol (T-Chol), HDL,
LDL, and hormones (insulin and leptin).
Serum concentrations of glucose, TG, T-Chol, HDL, and LDL
were assayed using a commercial kit (CELM, São Paulo, Brazil) and
measured with an automatic enzymatic analyzer system (Technicon,
RA-XTTM System; Global Medical Instrumentation, Ramsey, MN).
Leptin and insulin levels were determined by ELISA using commer-
cial kits (Linco Research, St. Louis, MO).
Glucose tolerance test and homeostatic model assessment index.
After the end of the experimental protocol, all rats were fasted for 4–6
h prior to the glucose tolerance test (48). After fasting, a blood sample
from the tip of the tail was collected. The basal blood glucose level of
each animal was immediately determined using a handheld glucom-
eter (Accuchek Advantage; Roche Diagnostics, Indianapolis, IN).
Subsequently, an injection of glucose solution (2 g/kg body wt)
dissolved in water was administered intraperitoneally, and blood
glucose levels were measured after 15, 30, 60, 90, and 120 min.
Glucose intolerance was evaluated by the area under the curve (AUC)
for glucose. HOMA-insulin resistance (IR) was expressed as an index
of insulin resistance and calculated using the following formula:
HOMA-IR  [fasting glucose (mmol/l)  fasting insulin (U/ml)]/
22.5.
Cardiac Remodeling
Cardiac remodeling was measured by morphological analysis post
mortem, histological study, echocardiographic evaluation, and papil-
lary muscle function, as well as by intracellular Ca2-cycling protein
analysis by Western blotting.
Morphological Analysis Postdeath
The rats were euthanized and after thoracotomy, the heart, ventri-
cles, and tibia were separated, dissected, weighed, and measured.
Cardiac remodeling at the macroscopic level, which identifies the
presence or absence of hypertrophy, was determined by analyzing the
following parameters: heart weight, LV weight, and their relation with
tibia length.
Histological Study
LV transverse sections of animals from each group were fixed in
10% buffered formalin and embedded in paraffin (49). Thick sections
of 5 m were cut from the tissue block and stained by routine
Gomori’s reticulin silver staining technique (5). After the silver
staining was developed, slides were mounted and visualized under
light microscopy to determine the myocyte cross-sectional area
(CSA), which was determined for at least 100 myocytes per slide and
used as an indicator of cell size.
The interstitial collagen fraction (CF) was determined for the entire
picrosirius red-stained cardiac section using an automatic image
analyzer (Image-Pro Plus 3.0). The components of the cardiac tissue
were identified according to color level as follows: red for collagen
fibers, yellow for myocytes, and white for interstitial space. The CF
was calculated as the sum of all connective tissue areas divided by the
sum of all connective tissue and myocyte areas. On average, 35
microscopic fields were analyzed using a 20 lens. Perivascular
collagen was excluded from this analysis.
Echocardiographic Evaluation
One week before euthanasia, echocardiographic evaluation was
performed using a commercially available echocardiograph (Philips
HDI-5000) equipped with a 5- to 12-MHz electronic transducer. Rats
were anesthetized by intramuscular injection of ketamine (50 mg/kg)
and xylazine (0.5 mg/kg). A two-dimensional parasternal short-axis
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view of the LV was obtained at the level of the papillary muscles.
M-mode tracings were obtained from short-axis views of the LV at or
just below the tip of the mitral valve leaflets and at the level of the
aortic valve and left atrium (49). M-mode images of the LV were
printed on a black-and-white thermal printer (Sony UP-890MD) at a
sweep speed of 100 mm/s. All measurements were obtained by the
same observer using the method recommended by the American
Society of Echocardiography (60).
The following LV structural variables were measured: left atrium
(LA) and aortic (AO) diameters, LV end-diastolic (LVDD) and LV
systolic (LVSD) dimensions, LV diastolic posterior wall thickness
(PWT), LV diastolic septal wall thickness (SWT), and relative wall
thickness (RWT). LV function was assessed by the following param-
eters: heart rate, endocardial and midwall fractional shortenings,
posterior wall shortening velocity (PWSV), early and late diastolic
mitral inflow (E-wave and A-wave, respectively), early-to-late dia-
stolic mitral inflow ratio (E/A ratio), E-wave deceleration time (EDT),
and isovolumetric relaxation time (IVRT).
Papillary Muscle Function
Isolated papillary muscles from LV were evaluated as previously
described (31). To determine the mechanism by which obesity induces
negative inotropic effects on contractile function, the papillary mus-
cles were evaluated under the baseline condition of 2.5 mM Ca2 and
after elevations of extracellular Ca2 concentration. Inotropic re-
sponses were recorded 5 min after the addition of each dose of
extracellular Ca2 (0.5, 1.0, 1.5, 2.0, and 2.5 mM) to the bathing
solution.
Myocardial L-type Ca2 Channel and SERCA2a Activity
To determine the activity or performance of L-type Ca2 channels
and SERCA2a during the myocyte contractile cycle, L-type Ca2
channel and SERCA2a blockers were employed. All drugs were
obtained from Sigma-Aldrich (St. Louis, MO).
The evaluation of L-type Ca2 channel activity was performed
using a specific inhibitor, diltiazem hydrochloride (104 M), in the
presence of cumulative Ca2 concentrations (0.5, 1.0, 1.5, 2.0, and 2.5
mM). Twenty minutes after diltiazem addition to the solution, each
concentration of Ca2 was separately added to the bathing solution for
10 min, and muscle function was evaluated. The result was expressed
as mean percent of inhibition. The solution of diltiazem was prepared
and diluted using double-distilled water.
To evaluate the role of SERCA2a, we used the highly specific
blocker, cyclopiazonic acid (CPA; 30 M), in the presence of cumu-
lative Ca2 concentrations (0.5, 1.0, 1.5, 2.0, and 2.5 mM). Sixty
minutes after CPA addition to the solution, each Ca2 concentration
was separately added to the bathing solution for 10 min, and the
papillary muscle response was analyzed. The data are expressed as
mean percent of inhibition (%).
At the end of the study, the parameters used to characterize the
papillary muscle were length (mm), weight (mg), and CSA (mm2).
The CSA was calculated from the length and weight of papillary
muscle, assuming uniformity and a specific gravity of 1.0. The muscle
length at Lmax was measured with a cathetometer (Gartner Scientific,
Chicago, IL), and the muscle between the two clips was blotted dry
and weighed.
Western Blot Analysis
At the end of the protocol, the levels of SERCA2a, CSQ, phos-
pholamban (PLB), PLB Ser16 phosphorylation (pPLB Ser16), PLB
Thr17 phosphorylation (pPLB Thr17), and L-type Ca2 channel were
determined by Western blot analysis. Briefly, LV samples were frozen
in liquid nitrogen from C (n  6) and Ob (n  6) rats and homoge-
nized in a buffer containing 50 mM potassium phosphate buffer (pH
7.0), 0.3 M sucrose, 0.5 mM DTT, 1 mM EDTA (pH 8.0), 0.3 mM
PMSF, 10 mM NaF, and phosphatase inhibitor cocktail (1:100;
Sigma-Aldrich). Samples were subjected to SDS-PAGE in 8–12%
polyacrylamide gels, depending on the molecular weight of the
protein. After electrophoresis, proteins were electrotransferred to
nitrocellulose membranes (Bio-Rad, Hercules, CA). Equal loading of
samples (50 mg) and transfer efficiency were monitored with 0.5%
Ponceau S staining of the membrane.
The blotted membrane was blocked (5% nonfat dry milk, 10 mM
Tris-HCl pH 7.6, 150 mM NaCl, and 0.1% Tween 20) for 2 h at room
temperature and then incubated overnight at 4–8°C with specific
antibodies against SERCA2a (1:2,500; ABR, Affinity BioReagents,
Golden, CO), CSQ (1:2,500; Upstate, Lake Placid, NY), PLB (1:500;
ABR, Affinity BioReagents), pPLB Ser16 (1:5,000; Badrilla, Leeds,
United Kingdom), pPLB Thr17 (1:5,000, Badrilla), and L-type Ca2
channel alpha 1C (1:100; Chemicon International, Temecula, CA).
Binding of the primary antibody was detected with peroxidase-
conjugated secondary antibodies (rabbit or mouse, depending on the
protein, for 2 h at room temperature), developed using enhanced
chemiluminescence (Amersham Biosciences, Piscataway, NJ), and
detected by autoradiography. Quantification analysis of blots was
performed by Scion Image software (Scion based on NIH image).
Targeted bands were normalized to the expression of -actin using an
antibody (1:1,000) obtained from Santa Cruz Biotechnology (Santa
Cruz, CA).
Statistical Analysis
Data on general characteristics, comorbidities, cardiac remodeling,
echocardiographic evaluation, papillary muscle function, and analysis
of key intracellular Ca2 cycling proteins were reported as the means
plus minus standard deviation. Comparisons between groups were
performed using Student’s t-test for independent samples. A repeated-
measures two-way ANOVA was utilized to evaluate the glucose
tolerance test and papillary muscle function; when significant differ-
ences were found (P 	 0.05), the Bonferroni or Student-Newman-
Keuls post hoc test for multiple comparisons was carried out. The
level of significance considered was 5% (
  0.05).
RESULTS
General Characteristics and Comorbidities
The general characteristics of rats after 30 wk are displayed
in Table 1 and Fig. 1. The long-term exposure to a high-fat diet
promoted a substantial elevation of final body weight, epidid-
ymal, retroperitoneal, and visceral fat pads, body fat and
Table 1. General and morphological characteristics of rats
after 30 wk
Variables
Groups
C Ob
IBW, g 153  7 151 11
FBW (g) at Week 3 294  12 315 14*
FBW (g) at 30 wk 489  33 608 22*
Epididymal fat, g 6.1  2.5 11.9 2.8*
Retroperitoneal fat, g 8.5 2.5 19.4 4.3*
Visceral fat, g 4.5  1.6 12.0 3.0*
Body fat, g 19.1  5.4 43.3 8.2*
Adiposity index, % 3.9  0.9 7.1 1.3*
HW, g 1.14  0.09 1.28 0.11*
LVW, g 0.81  0.07 0.90 0.09*
HW/Tibia, g/cm 0.26 0.02 0.28 0.03*
LVW/Tibia, g/cm 0.18 0.02 0.20 0.02*
Values are means  SD (n  10 animals). C, control; Ob, obese; IBW,
initial body weight; FBW, final body weight; HW, heart weight; LVW, left
ventricle weight; *P 	 0.05 vs. C. Student’s t-test for independent samples.
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adiposity index. There was no significant difference between
the groups for initial body weight. Ob rats had a body fat
content (126.7%) and an adiposity index (82.1%) that was
significantly greater than in C rats. Epididymal, retroperitoneal,
and visceral fat pads were increased by 95%, 128%, and 166%
in Ob rats. Figure 1 and Table 1 illustrate that a significant
separation of body weight between the two diet groups was
observed from Week 3 that continued throughout the rest of the
study (30 wk), determining the initial moment of obesity.
The comorbidities associated with obesity are summarized
in Table 2. Long-term high-fat diet-induced obesity caused
significant metabolic and hormonal alterations. The glucose,
AUC, insulin, HOMA-IR, TG, and leptin levels were higher in
Ob rats than in C rats. Furthermore, the glucose tolerance test
(data not shown) and HOMA-IR revealed compromised glu-
cose tolerance and insulin resistance in the Ob rats. The other
parameters including SBP, T-Chol, HDL, and LDL were sim-
ilar between the groups.
Cardiac Remodeling
Figure 2 and Table 3 show the influence of obesity on the
structural cardiac remodeling process. Absolute heart weight,
LV weight, heart-to-tibia length ratio, and LV-to-tibia length
ratio were significantly elevated in Ob rats compared with
those in the C group. Additionally, the histological analysis
revealed that cardiomyocyte CSA was higher in Ob rats than in
C rats (Fig. 2A). Moreover, the long-term diet-induced obesity,
after 30 wk, did not promote alterations in the LV interstitial
collagen fraction (Fig. 2B). Echocardiography revealed signif-
icantly greater values of LVSD, LVDT, SWT, PWT, and RWT
in Ob rats compared with C rats. LVDD, LA and AO diame-
ters, LA/AO ratio, and LV mass were similar between the
groups (Table 3).
LV functional data are shown in Table 4. Echocardiographic
evaluation showed that Ob rats had increased fractional short-
ening (FS) endocardial, FS midwall, PWSV, and A-wave
compared with C rats. Cardiac index, E/A ratio, and IVRT
were lower in Ob rats than in C rats. Heart rate, cardiac output,
E-wave, and EDT did not differ between the groups.
Papillary Muscle Function Evaluation
Figure 3 summarizes the mechanical properties of isolated
papillary muscle from control and obese rats at baseline and
after Ca2 stimulation. Long-term obesity did not promote
contractile dysfunction at basal condition and after inotropic
intervention. Maximum developed tension (DT) was similar
between the C and Ob rats under basal conditions (C: 5.87 
1.0 g/mm2 and Ob: 5.93  1.05 g/mm2) and after maneuver
(Fig. 3, A and D). Additionally, long-term obesity failed to
elicit any significant effect on dT/dt and dT/dt at baseline
and after maneuver, suggesting that intracellular Ca2 entry
and resequestration were not compromised in Ob rats (Fig. 3,
B, C, E, and F).
Figure 4 shows the myocardial L-type Ca2 channel and
SERCA2a activity from C and Ob rats. The myocardial dys-
function induced by long-term obesity was not related to
L-type Ca2 channel impairment and damage on SERCA2a
performance. The maximal inhibition of DT in response to
diltiazem was 84 5% and 88 3% at a Ca2 exposure of 0.5
mM in C and Ob rats, respectively, but without significant
effects between the groups (Fig. 4A). At the same time,
diltiazem displayed similar negative inotropic behavior on
dT/dt without significant changes between the groups (Fig.
4B). This result suggests that long-term exposure obesity (30
wk) did not impair L-type channel activity and myocardial
Ca2 entry.
Figure 4, C-D, shows the influence of the SERCA2a inhib-
itor (CPA; 30 M) in the presence of cumulative Ca2 con-
Table 2. Comorbities and hormones associated with obesity
Variables
Groups
C Ob
SBP, mmHg 127  8 127  16
Glucose, mg/dl 91  4 103  4*
AUC, mg·dl1·min1 14,937  3,029 20,631  4,096*
Insulin, mg/dl 0.81  0.10 1.18  0.18*
HOMA-IR 13 2 21  3*
TG, mg/dl 54  9 93  19*
T-Chol, mg/dl 71  9 73  16
HDL, mg/dl 25  4 26  4
LDL, mg/dl 15  3 14  2
Leptin, ng/ml 2.98  0.78 8.16  2.71*
Values are means  SD (n  10 animals). C, control; Ob, obese; SBP,
systolic blood pressure; AUC, area under the curve for glucose; HOMA-IR,
homeostatic model assessment index; TG, triglycerides; T-Chol, total choles-
terol. *P 	 0.05 vs. C. Student’s t-test for independent samples.
Fig. 1. Evolution of body weight during 30 wk of experimental protocol after beginning of obesity (at Week 3). Two-way ANOVA for independent samples and
Bonferroni’s post hoc analysis. C, control; Ob, obese; BW, body weight. Data are means  SD. *P 	 0.05 vs. control.
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centrations on DT and dT/dt in LV papillary muscle from C
and Ob rats. Although this drug produced negative inotropic
effects on DT in both groups, alterations were observed under
low concentrations of Ca2 (0.5, 1.0, and 1.5 mM; Fig. 4C),
with significant effects between the groups (maximal inhibition
of DT; C  Ob). Additionally, CPA produced a similar
response ondT/dt between groups, despite significant change
in Ca2 concentration (0.5 mM; Fig. 4D). This result suggests
that long-term obesity (30 wk) did not depress SERCA2a
activity and cardiac sarcoplasmic reticulum Ca2 transport.
Intracellular Ca2 Cycling Proteins
The levels of intracellular Ca2 cycling proteins SERCA2a,
CSQ, PLB, pPLB Ser16, pPLB Thr17, and L-type Ca2 channel
were assessed to determine the mechanism for obesity-induced
changes on cardiac function. These results are summarized in
Figs. 5 and 6. Figure 5 shows that obesity did not change the
protein levels of SERCA2a, PLB, CSQ, and L-type Ca2
channel. Furthermore, the SERCA2a/PLB ratio was also sim-
ilar between groups (Fig. 5). Additionally, as shown in Fig. 6,
protein levels of pPLB Ser16 (C: 1.00  0.25 vs. Ob: 0.66 
0.12; P 	 0.02) and the pPLB Ser16/PLB ratio (C: 1.00  0.17
vs. Ob: 0.62  0.20; P 	 0.005) were significantly diminished
in Ob rats. Protein levels of pPLB Thr17 and pPLB Thr17/PLB
were similar between the groups (Fig. 6).
DISCUSSION
The adverse effects of obesity have been extensively studied
in experimental models (13, 31, 50, 53, 56). Interestingly,
although several mechanisms have been postulated to identify
obesity-induced cardiac dysfunction, little information is avail-
able on the relationship between the duration of obesity,
Table 3. Cardiac structural parameters analyzed
by echocardiogram
Variables
Groups
C Ob
LVDD, mm 8.66 0.50 8.51 0.44
LVSD, mm 4.74 0.36 4.13 0.36*
LVDT, mm 1.51 0.04 1.58 0.05*
SWT, mm 1.52 0.04 1.59 0.04*
PWT, mm 2.71 0.15 2.96 0.18*
RWT 0.17 0.01 0.19 0.01*
LA, mm 5.74  0.50 5.78 0.44
AO, mm 4.13  0.21 4.17 0.16
LA/AO 1.39 0.12 1.39 0.11
LV mass 0.99 0.12 1.02 0.10
Values are means  SD. LV, left ventricle; LVDD, LV end-diastolic
dimension; LVSD, LV end-systolic dimension; LVDT, diastolic thickness of
the left ventricle; SWT, diastolic septal wall thickness; PWT, LV diastolic
posterior wall thickness; RWT, relative wall thickness; LA, left atrium diam-
eter; AO, aortic diameter. *P 	 0.05 vs. C. Student’s t-test for independent
samples.
Table 4. Left ventricular functional data analyzed
by echocardiogram
Variables
Groups
C Ob
HR, bpm 290  28 308  44
Cardiac output, ml/min 158  29 168  24
Cardiac index, ml·min1·g1 332  61 276  38*
FS endocardial, % 45.3  2.5 51.5  3.3*
FS midwall, % 28.4  2.3 31.9  2.4*
PWSV, mm/s 34.8  2.9 39.7  2.2*
E-wave, cm/s 73.1  7.8 77.1  8.6
A-wave, cm/s 47.4  8.6 66.6  14.3*
E/A 1.59  0.34 1.20  0.26*
EDT, ms 48.9  9.8 49.5  7.8
IVRT, ms 31.3  3.4 25.8  2.9*
Values are means  SD (n  10 animals). HR, heart rate; bpm, beats per
minute; FS, fractional shortening; PWSV, posterior wall shortening velocity;
E/A, early-to-late diastolic mitral inflow ratio; EDT, E-wave deceleration time;
IVRT, isovolumetric relaxation time. *P 	 0.05 vs. C. Student’s t-test for
independent samples.
Fig. 2. Histological study in myocardium from control (open bars) and obese (closed bars) rats after 30 wk. A: myocyte cross-sectional area (CSA; 40
magnification); left ventricular (LV) cross-sections obtained by Gomori staining for reticulin. B: interstitial collagen of myocardium (20 magnification);
representative picrosirius red-stained LV section. Arrows, interstitial collagen of control and obese rats. Data are means  SD. *P 	 0.05 vs. control. Student’s
t-test for independent samples. Bar, 20 m.
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cardiac function, and Ca2 protein regulation. The major
finding in the current study was that cardiac dysfunction in Ob
rats, after long-term obesity, was related to the reduction of
PLB phosphorylation at Ser16 without affecting cardiac cal-
cium influx and recapture.
In this study, the chronic feeding of a diet rich in unsaturated
fat induced obesity in rats. The high-fat diet used was of
sufficient intensity and duration to promote obesity in the
experimental time period of 30 wk. According to the literature,
fat-enriched diets have been used for decades to model obesity
in rodents (11). The development of obesity was characterized
by significant differences in body weight, body fat, fat pads,
and adiposity index compared with control rats. The animal
models in this study also presented almost all the features of
metabolic syndrome, such as central obesity, glucose intoler-
ance, hypertriglyceridemia, and insulin resistance; but systolic
Fig. 3. Basal condition (A, B, and C) and effects of increasing extracellular Ca2 concentration (D, E, and F) in papillary muscles from control (open bars) and
obese (closed bars) rats after 30 wk. DT, maximum developed tension;dT/dt, peak of positive tension derivatives;dT/dt, peak of negative tension derivatives.
All parameters normalized per cross-sectional area. Data are means  SD. *P 	 0.05 vs. control. Student’s t-test for independent samples (A, B, and C) and
repeated-measures two-way ANOVA (D, E, and F); Student-Newman-Keuls post hoc test.
Fig. 4. L-type Ca2 channels (A and B)
and sarcoplasmic reticulum Ca2-ATPase
(SERCA2a; C and D) activity in papillary
muscles from control (open bars) and obese
(closed bars) rats after 30 wk; diltiazem and
cyclopiazonic (CPA) experiment: 10 rats per
group. All parameters normalized per cross-
sectional area. DT and negative tension deriv-
atives normalized per cross-sectional area.
Data are mean percent of inhibition (%) SD.
*P 	 0.05 vs. control. Repeated-measures
two-way ANOVA; Student-Newman-Keuls
post hoc test.
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blood pressure was not affected by long-term obesity. Consis-
tent with previous investigations, the high-fat diet used in this
study was effective at promoting numerous comorbidities as-
sociated with long-term obesity (19, 24, 33, 34, 43).
Morphological analysis postdeath, histological study, and
echocardiographic assessment can identify relevant pathophys-
iological changes in structure and cardiac function during the
progression of cardiovascular diseases associated, for example,
with obesity. The present study showed that Ob rats developed
cardiac hypertrophy compared with C rats. This structural
alteration was visualized by higher total heart and LV weights;
elevated cardiomyocyte CSA; and greater values of LVDD,
LV diastolic thickness, LV diastolic SWT, PWT, and RWT. In
the present investigation, obesity did not lead to an increase in
interstitial collagen deposition in the LV. The mechanisms
underlying the accumulation of collagen in Ob animals remain
unknown; Brands et al. (10) suggested that the higher collagen
concentration is linked to abnormalities in insulin metabolism,
and other authors reported that it is associated with elevation of
cytokines, endothelin, and renin-angiotensin-aldosterone (52,
59). These findings suggest that, in the current study, there was
a remodeling of cardiac processes after a long period of
obesity, without alterations in the levels of collagen. Rider et
al. (57) proposed that cardiac remodeling is an adaptive char-
acteristic of obesity.
Obesity-induced changes in cardiac structure may be elicited
directly, by obesity-induced increases in cardiac loading con-
ditions (preload and afterload), or indirectly, by obesity-in-
duced cardiometabolic abnormalities such as dyslipidemia and
insulin resistance and/or diabetes (1, 73). Dhanasekaran et al.
(18) reports that insulin resistance induced by obesity with
associated hyperinsulinemia could promote cardiac remodeling
via the growth-promoting properties of insulin or by attenuat-
ing the antiapoptotic signaling of the phosphatidylinositol
3-kinase (PI3-K)/Akt pathway elicited by insulin receptor
activation. Our data are in agreement with previous findings
that have shown cardiac remodeling in long-term obesity
(34, 43, 53).
For cardiovascular function, the cardiac remodeling induced
by long-term obesity promoted significant functional changes
after 30 wk compared with C rats. The main findings were
visualized by measuring endocardial and midwall FS, posterior
wall shortening velocity, A-wave, E/A ratio, and IVRT. Within
this context, although Ob rats did not present an increase in LV
end-systolic volume (data not shown), there was an improve-
ment of LV ejection as evaluated by endocardial and midwall
FS and posterior wall shortening velocity; these data corrobo-
rate the reduction of the LV end-systolic dimension. These
parameters depend on the following factors: contractility, load
variations, and heart rate; therefore, these parameters are in-
fluenced by the hormonal and autonomic nervous systems (45).
An explanation for the elevated systolic function may be
related to decreased afterload and LV contractility improve-
ment. Our data differ from some experimental studies that
found decreased or unchanged systolic function by echocardi-
ography (13, 20, 32).
The literature shows that studying LV diastolic function is
very important because changes in the filling of this cavity may
precede systolic dysfunction (28). In this study, long-term
obesity increased the A-wave and promoted a reduction of the
E/A ratio, indicating impairment of cardiac filling. These data
suggest that obesity caused mild alterations in diastolic func-
tion due to the absence of changes in the E-wave, EDT, and
decreased IVRT. According to some authors, IVRT prolonga-
tion is the most consistent diastolic abnormality observed in
obese individuals (6, 41, 74). Furthermore, a higher A-wave
and a lower E/A ratio suggest the presence of diastolic dys-
function (25, 26, 41). Diastolic filling depends on the active
relaxation and passive properties of cardiac muscle, while the
former is associated with Ca2 handling (16, 55); the latter
depends on myocardium viscoelastic properties (8, 9, 72).
Diastolic dysfunction in obesity models are not clarified (27,
61), but may be associated with insulin resistance, hyperinsu-
linemia, hyperglycemia, hemodynamic changes, and/or Ca2-
handling homeostasis. Impaired insulin metabolic signaling
and increased generation of reactive oxygen species play im-
portant roles in maladaptive myocardial remodeling (1, 63, 67).
Cardiac function was also evaluated in vitro by studying LV
isolated papillary muscle. Our results showed that long-term
Fig. 6. Cardiac protein expression from control (open bars) and obese (closed
bars) rats after 30 wk. pPLB Thr17, PLB threonine-17 phosphorylation; pPLB
Ser16, PLB serine-16 phosphorylation. Data are means  SD *P 	 0.05 vs.
control. Student’s t-test for independent samples.
Fig. 5. Cardiac protein expression from control (open bars) and obese (closed
bars) rats after 30 wk. PLB, phospholamban; CSQ, calsequestrin; L-Type
Ca2, L-Type Ca2 channel. Data are means  SD. Student’s t-test for
independent samples. There is no statistical difference between the groups.
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obesity did not promote contractile dysfunction after Ca2
stimulation. In addition, long-term obesity failed to cause any
significant effect on dT/dt and dT/dt, suggesting that in-
tracellular Ca2 entry and resequestration were not compro-
mised in Ob rats even with downregulation of cardiac pPLB
Ser16. Alterations in intracellular Ca2 handling have been
described in obese rodents (31, 35, 50, 53), but there are few
studies that verified these changes after long-term obesity. In
the current study, although there was damage in the PLB
phosphorylation at Ser16 after long-term obesity, the absence of
changes in SERCA2a suggests that there was a compensatory
mechanism in the Ca2 handling.
The absence of changes after long-term obesity may be
related to the type of high-fat diet utilized in this study, which
was rich in unsaturated fatty acids. Increasing the time of
exposure to an unsaturated high-fat diet may have caused a
protective effect on the heart, unlike what was seen earlier by
Leopoldo et al. (31). Several studies have shown that dietary
fat intake plays a significant role in the development of car-
diovascular disease (15, 17, 23, 44, 70). Although some con-
troversy still exists as to the role of high-fat diets in human and
animal health and disease, it is well accepted that dietary
saturated fatty acid is positively associated with cardiovascular
risk and, consequently, to damage of cardiac function (23, 36,
44, 70). In contrast, high-fat diets consisting of polyunsaturated
fatty acid or those rich in monounsaturated fatty acid have
beneficial effects on plasma lipids, fatty acid tissue composi-
tion, blood pressure, and myocardium structure and function in
rats (3, 17, 36, 44, 58), and have been associated with low
cardiovascular mortality (15).
Our data revealed impaired regulation of intracellular Ca2
protein following long-time exposure to unsaturated high-fat
diet intake, manifested by a reduction of PLB phosphorylation
at Ser16. PLB phosphorylation of Ser16 and Thr17 by PKA or
CaMKII is physiologically relevant for controlling SERCA2a
activity (2, 38, 62). Ser16 and Thr17 phosphorylation is believed
to be part of a sequential model that requires the phosphory-
lation of Ser16 before Thr17 (2, 38, 62). However, studies have
shown that an individual and independent phosphorylation may
occur at the two sites (12, 14). PLB phosphorylation/dephos-
phorylation is regulated by a pool of kinases upstream and by
a pool of phosphatases and other regulatory proteins down-
stream. The major stimulus for controlling PLB activity is
related to the -adrenergic system. Activation of cardiac -ad-
renergic receptors induces PLB phosphorylation at Ser16 and
Thr17 via the PKA and CaMKII pathways, although PKA-
dependent Ser16 phosphorylation is considered to be prevalent
(12). Overall, our results indicate that PLB dephosphorylation
at Ser16 contributes to the alterations in diastolic function
observed after 30-wk diet-induced obesity. A possible expla-
nation for the impairment of PLB phosphorylation at Ser16 in
obese rats may be related to downregulation of the -adrener-
gic system.
Another important feature of PLB phosphorylation at Ser16
is that this site is more physiologically important than Thr17
due mainly to the lower level of phosphorylation at Thr17 (12,
40). Phosphorylation of PLB at Thr17 must be potentiated by
Ser16 phosphorylation, and Thr17 phosphorylation has a negli-
gible effect after Ser16 has been phosphorylated (2, 38). Thus,
although alteration in PLB phosphorylation at Thr17 was not
observed, the damage to phosphorylation at Ser16 visualized in
obese rats could impair phosphorylation at Thr17. On the
other hand, phosphorylation of PLB at Thr17 does not appear
to affect significantly interactions with SERCA, suggesting
that the mechanism of releasing the inhibitory effect is
different between Thr17-phosphorylated and Ser16-phos-
phorylated PLB (62).
In disagreement with our hypothesis, obesity did not affect
SERCA2a, CSQ, and L-type Ca2 channel protein levels. One
explanation for such a result is that the mechanisms responsible
for modulating these proteins, directly or indirectly, were not
changed by obesity. Leopoldo et al. (31) showed that, despite
the lack of changes in the level of L-type Ca2 channel protein,
the myocardial dysfunction caused by obesity after 15 wk was
related to L-type Ca2 channel activity impairment, suggesting
that the -adrenergic system was damaged. Although there was
damage to PLB phosphorylation at Ser16 in this study, the
absence of changes in L-type Ca2 channel activity and ex-
pression suggests that other mechanisms are involved after
long-term exposure to obesity.
In conclusion, our study shows that long-term exposure to
obesity promotes alterations in diastolic function due to reduc-
tion of PLB phosphorylation at Ser16 but does not impair
cardiac Ca2 influx and recapture.
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